International Clinical Trial: Prediction of SBRT Efficacy and Personalized Treatment Strategies in Early-Stage NSCLC Patients Based on Multimodal Imaging and Temporal Analysis

Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120905) titled 'Prediction of SBRT Efficacy and Personalized Treatment Strategies in Early-Stage NSCLC Patients Based on Multimodal Imaging and Temporal Analysis' on March 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shandong First Medical University Affiliated Tumor Hospital

Condition: Non-small cell lung cancer

Intervention: Training and validation cohort:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-01

Target Sample Size: Training and validation cohort:300;Prospective cohort:150;

Countries of Recruitment: China

To know more, visit http...